Anna Hohler, MD
Neurology · Brockton, MANPI 1689646606
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Boston Scientific at 50.1% of the total. 2025 is the largest year on record at $3,726, 3.0 times the $1,228 reported in 2019.
Across 83 payments — averaging $76.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Medtronic$2K
- Acadia Pharmaceuticals Inc$439
- Amneal Pharmaceuticals LLC$427
- AbbVie$369
- MDD US Operations, LLC$116
- plus $283 from 4 others
Across 33 payments — averaging $3638.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$120K
What the payments were for
- Travel & lodging$3,27351%
- Food & beverage$3,09749%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 14 | $3,192 |
| Medtronic(2 entities) | 17 | $1,552 |
| Acadia Pharmaceuticals Inc | 8 | $439 |
| Amneal Pharmaceuticals LLC | 24 | $427 |
| AbbVie(2 entities) | 10 | $369 |
| MDD US Operations, LLC | 1 | $116 |
| Pfizer | 6 | $115 |
| Jazz Pharmaceuticals Inc. | 1 | $114 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| Siemens Medical Solutions USA, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VERCISE$2,798
- ACTIVA$757
- PERCEPT PC BRAINSENSE$243
- NUPLAZID$138
- GENERAL DBS$129
- Duopa$125
- SUNOSI$114
How this compares
$6,377 in reported general payments places this provider in the 75th percentile of 761 neurology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 18 | $160,300 |
| BetaseronInterferon Beta-1b | 13 | $124,754 |
| RytaryCarbidopa/Levodopa | 41 | $86,225 |
| Droxidopa | 19 | $62,074 |
| GocovriAmantadine Hcl | 16 | $49,530 |
| AustedoDeutetrabenazine | 11 | $48,626 |
| Nurtec OdtRimegepant Sulfate | 22 | $38,679 |
| Tetrabenazine | 13 | $33,005 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 681 | $29,656 |
| Memantine Hcl | 473 | $23,873 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 191 | $22,999 |
| Rasagiline Mesylate | 120 | $22,739 |
| NeuproRotigotine | 14 | $21,059 |
| Glatiramer Acetate | 15 | $20,776 |
| AmantadineAmantadine Hcl | 290 | $19,673 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Acadia Pharmaceuticals IncNuplazid | $439 | $160,30018 claims |
| Amneal Pharmaceuticals LLCRytary, Pyridostigmine Bromide | $427 | $105,380161 claims |
| MDD US Operations, LLCGocovri | $116 | $49,53016 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $30 | $48,62611 claims |
| PfizerNurtec Odt | $115 | $38,67922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 761 neurology providers in Massachusetts.
Other neurology in Brockton
- Christopher WrightBoston$2.5M
- Shivang JoshiWestborough$1.2M
- Egilius SpieringsWellesley Hills$680K
- Thomas ScammellBoston$617K
- Salvatore NapoliFoxboro$613K
- Alfred SandrockBoston$490K
- Joshua KatzWellesley$462K
- Guy BuckleBrookline$450K
- Pushpa NarayanaswamiBoston$420K
- Kenneth GorsonWellesley$414K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.